ACADIAN SEAPLANTS LIMITED

Acadian Seaplants Limited (ASL) is a bio-tech company and the largest independent manufacturer of marine plant products of its type in the world. It is engaged primarily in the sustainable harvesting of wild seaweeds and in the cultivation of unique marine plants for the development of value-added seaweed products. Through five processing plants located in the Maritime provinces, the company processes thousands of tons of marine plants annually providing quality products to global food and agricultural industries. Its value-added products are sold into health, beauty, brewery, nutriceutical and pharmaceutical markets, agricultural markets involving animal feeds and specialty fertilizer products such as nutritional products, plant growth regulators and crop biostimulants. The company also cultivates and processes unique seaweeds for the Asian food market.

Several noteworthy aspects of ASL’s operations include: advanced sustainable seaweed harvesting methods, renewable resource and the technologies created to process the natural seaweed resources into value-added finished products for sale in exacting global markets.

Acadian Seaplants Limited is a recognized industry leader in the manufacturing of seaweed-based products and has advanced both the fundamental and applied scientific study of seaweeds and is responsible, in real terms, for advancing, on a global scale, the understanding of the biochemistry and processing of seaweeds and their benefits. Given the technical nature of the research work conducted at ASL, the company has assembled an expert scientific team. In addition to the company’s own compliment of technical staff, ASL works with local research partners and contracts research to international organizations as required. Approximately 95% of ASL’s products are exported to 70 countries worldwide.

Acadian Seaplants is celebrating its 25th anniversary 1981 – 2006.

"Innovation is the basis for competitive advantage in our industry, and success hinges on the ability to build technical relationships and to commercialize the science.” says Jean-Paul Deveau, ASL President.